檢索結果 - April Franks
- Showing 1 - 3 results of 3
-
1
-
2
Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous... 由 Robert L. Ferris, C. Even, Robert Haddad, Makoto Tahara, Trishna Goswami, April Franks, Ugochi Emeribe, Anthony Jarkowski, Giovanni Melillo, Lisa Licitra
出版 2015Artigo -
3
OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models 由 Andrew J. Garton, Andrew P. Crew, Maryland Franklin, Andrew Cooke, Graham M. Wynne, Linda Castaldo, Jennifer Kahler, Shannon L. Winski, April Franks, Eric Brown, Mark Bittner, John F. Keily, Paul Briner, Chris Hidden, Mary C. Srebernak, Carrie Pirrit, Matthew O’Connor, Anna Chan, Bojana Vulevic, Dwight Henninger, Karen Hart, Regina Sennello, An‐Hu Li, Tao Zhang, Frank C. Richardson, David L. Emerson, Arlindo L. Castelhano, Lee D. Arnold, Neil W. Gibson
出版 2006Artigo
相關主題
Medicine
Oncology
Basal cell
Biochemistry
Biology
Biotechnology
Cancer
Chemistry
Chemotherapy
Durvalumab
Head and neck
Head and neck cancer
Head and neck squamous-cell carcinoma
Immune system
Immunology
Immunotherapy
In vitro
In vivo
Intensive care medicine
Internal medicine
Ipilimumab
Kinase
Law
Lung cancer
MEDLINE
Nivolumab
Pharmacokinetics
Pharmacology
Political science
Potency